Navigation Links
1 Award Winner and 9 Prize Winners in the EFQM Business Excellence Awards

MUNICH, October 26, 2011 /PRNewswire/ --

Bilim Pharmaceuticals wins the EFQM Excellence Awards 2011, the first pharmaceutical company ever to win the Award. Presented annually by EFQM, the award recognizes business performance measured against Europe's most widely used management framework: the EFQM Excellence Model. Another 9 organisations received Prizes for role model behaviour in one of the 8 Fundamental Concepts of Excellence.

118 independent assessors visited 20 organisations earlier this year, spending a total of 10 000 man hours analyzing results and interviewing people. The Finalists, Prize and Award winners celebrated their victories last night at BMW Welt, in the precense of  Martin Zeil, Bavarian Minister for Economic Affairs and Deputy Bavarian Prime Minister.

EFQM's CEO, Mr. Pierre Cachet comments: "We have not seen such a high number of Prize and Award winners since 2005 ! Also, this year we have recognised the first organisation, based on a global scale assessment; Bosch Chassis Systems,who received a Prize for Leadership. All of this proves that Business Excellence is a vital strategy for European organisations and remains at the top of the business agenda."

From 30 000 organisations implementing the EFQM Excellence Model worldwide, these are this year's Winners:

Company Country Prize Bilim Pharmaceuticals Turkey Award Winner Bosch Chassis Systems Control Global Prize winner Robert Bosch Bamberg Plant Germany Prize Winner RED Spain Prize Winner Ricoh Deutschland Germany Prize Winner Liverpool John Moores University UK Prize Winner Coplaning Luxembourg Prize Winner Grundfos Pumpenfabrik Germany Prize Winner Siemens Healthcare UK Prize Winner Hôpital Kirchberg Luxembourg Prize winner


Photos of the Award ceremony are available here:

About EFQM

EFQM is a global not-for-profit membership foundation based in Brussels, Belgium. With more than 500 members covering more than 55 countries and 50 industries, we provide a unique platform for organisations to learn from each other and improve performance. EFQM is the custodian of the EFQM Excellence Model, a business model which is helping over 30 000 organisations around the globe to strive for Sustainable Excellence. (


Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Metabolomx Awarded $1.14 Million SBIR Grant from National Cancer Institute for Breath Analysis Test of Lung Cancer
2. SAIC Awarded Contract by National Institute of Allergy and Infectious Diseases
3. Cellular Dynamics Internationals (CDI) Human Induced Pluripotent Stem Cell (iPSC) Technology Named the Gold Winner in The Wall Street Journal 2011 Technology Innovation Awards
4. StriVectin® Receives Annual Skin Sense Award
5. Penn team wins entrepreneurial innovation award
6. Notre Dame researchers awarded millions to develop radically new computers
7. United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program
8. KGI Professor Awarded Patent for Stem-Cell Therapy Aiding Heart-attack Patients
9. SRI International Awarded Two National Cancer Institute Preclinical Development Service Contracts
10. The Japanese Cancer Association and Debiopharm Group™ Present Doctors Arakawa and Kurokawa With the 2011 JCA-Mauvernay Award for Their Innovative and Outstanding Research in the Field of Cancer
11. ClinicalRM Awarded Omnibus III Contracts to Support the Navy Medical Research Center (NMRC)
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):